BridgeBio Gets First Drug Approval In Ultra-Rare MoCD Type A

 
• By Joseph Haas
FDA approved background, 3D rendering, blue street sign
Nulibry for MoCD type A is BridgeBio's first approved drug

More from New Products

More from Scrip